Inactive Instrument
Evolutionary Genomics, Inc. Stock Other OTC
Stocks
FNAM
US30051F1012
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 2.99M 2.6M 2.43M 2.22M 4.18M 286M 4.24M 28.65M 11.19M 143M 11.24M 11M 477M | P/E 2021 |
-1.34x | P/E 2022 | -2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.16M 5.34M 5.01M 4.57M 8.59M 588M 8.73M 58.95M 23.01M 294M 23.13M 22.63M 982M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
67.35% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -10.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Walter Messier
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/01/2000 |
Steve Warnecke
CEO | Chief Executive Officer | 70 | 01/10/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Steve Warnecke
CHM | Chairman | 70 | 01/10/2014 |
| Director/Board Member | 76 | 01/01/2000 | |
Mark Boggess
BRD | Director/Board Member | 66 | 01/01/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -10.00% | -.--% | - | - | 1.33K | ||
| +1.17% | +2.03% | +4.91% | +15.74% | 48.72B | ||
| -1.59% | +2.38% | +472.89% | +573.56% | 43.99B | ||
| -0.85% | +8.70% | +23.57% | +80.09% | 40.82B | ||
| -0.08% | +2.32% | +29.91% | +9.86% | 39.79B | ||
| 0.00% | +6.15% | +23.03% | +48.00% | 32.7B | ||
| -2.52% | -0.99% | +26.71% | +118.05% | 16.66B | ||
| -3.61% | +0.83% | - | - | 16.84B | ||
| +0.72% | +0.60% | +4.97% | +21.70% | 13.95B | ||
| -1.09% | +7.88% | +84.14% | +31.15% | 13.58B | ||
| Average | -1.71% | +3.71% | +83.77% | +112.27% | 29.67B | |
| Weighted average by Cap. | -0.47% | +3.66% | +102.34% | +135.59% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.79M -2.42M -2.27M -2.07M -3.89M -267M -3.96M -26.73M -10.44M -133M -10.49M -10.26M -445M | -1.93M -1.68M -1.57M -1.43M -2.7M -185M -2.74M -18.51M -7.23M -92.44M -7.26M -7.11M -308M |
| Net Debt | 3.53M 3.06M 2.87M 2.62M 4.92M 337M 5M 33.77M 13.18M 169M 13.25M 12.96M 563M | 3.17M 2.74M 2.57M 2.35M 4.41M 302M 4.49M 30.3M 11.83M 151M 11.89M 11.63M 505M |
Employees
-
















